drugset / Trial / NCT03160261
Effect of Exenatide on Cortisol Secretion
NaSingle-groupOpen-labelDiagnostic
Summary
The primary aim of the study is to describe the effect of single dose of 10 micrograms (μg) exenatide given subcutaneously (s/c) on cortisol secretion. Secondary outcomes involve ACTH and glucose levels.
Timeline
- Start
- 2017-09-07
- Primary completion
- 2017-12-28
- Completion
- 2017-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 10 ug | Subcutaneous |
Indications
No indication recorded.